Economic Evaluation of Population-Level Chronic Kidney Disease Interventions in the UK National Health Service.

ABSTRACT: Background: Chronic kidney disease (CKD) affects 13% of the global population, is predicted to be the fifth leading cause of premature death by 2040, and is associated with increased risk of cardiovascular disease and acute cardiovascular events. With an aging population and rising diabetes rates, the prevalence of CKD is expected to escalate in the United Kingdom, leading to substantial healthcare costs. When patients reach end-stage kidney disease, interventions such as dialysis and transplantation are required. Dialysis is not only extremely costly but is also associated with a diminished quality of life and significantly elevated mortality. Objectives: This study assesses the cost-effectiveness of several population-level interventions designed to manage CKD, including it

SUBMITTER: Agathangelou G 

PROVIDER: S-EPMC12047453 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature